← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Icon Government And Public Health Solutions, Inc.
Hinckley, OH
$50,931,438
Total funding
5
Grants
Funding over time
peak $12.5M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,931,438 · 5
By mechanism
N01$48,238,384 · 4
N02$2,693,054 · 1
Investigators at Icon Government And Public Health Solutions, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$5,651,802
N01 · FY2012 · AI
Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Contract$5,264,944
N01 · FY2024 · AI
Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Contract$3,850,000
N01 · FY2024 · AI
Phase I Clinical Trial Unit for Therapeutics$2,730,209
N01 · FY2008 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$2,659,562
N01 · FY2012 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$2,592,417
N01 · FY2012 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$2,409,113
N01 · FY2014 · AI
PHASE I CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES$2,000,000
N01 · FY2011 · AI
EPCTU: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Tuberculosis$1,962,150
N01 · FY2023 · AI
PHASE I CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES$1,753,448
N01 · FY2011 · AI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS$1,642,152
N01 · FY2018 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$1,640,796
N01 · FY2013 · AI
PHASE I CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES$1,500,000
N01 · FY2011 · AI
Phase 1 Clinical Trial Units for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for Dengue Virus$1,472,261
N01 · FY2017 · AI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR COCCIDIOIDES IMMITIS$1,441,784
N01 · FY2018 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$1,196,787
N01 · FY2012 · AI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS$1,185,838
N01 · FY2020 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$1,017,211
N01 · FY2015 · AI
Sexually Transmitted Infections Clinical Trials Group$905,560
N01 · FY2013 · AI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$607,020
N01 · FY2013 · AI